Product Information
LITHIUM CARBONATE 150 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0963 per EA under NDC 62332001331. Its NADAC has been published 434 times since Jun 13, 2018.
FDA first approved this application on Jan 12, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001331
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA079159FDA Approved
1/12/2009
TE Code
AB
On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 150 MG CAP has been published 434 times since Jun 13, 2018, and over the history we have for it it has risen 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1032 (Jan 10, 2024) |
| All-time low | $0.0626 (Dec 22, 2021) |
| 52-week high | $0.0963 |
| 52-week low | $0.0847 |
| Median price | $0.0813 |
| Average price | $0.0827 |
| Largest weekly change | +25.9% (Aug 21, 2024) |
| Weeks tracked | 434 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LITHIUM CARBONATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LITHIUM CARBONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mood Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 150 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.0963 per EA (NDC 62332001331), effective Sep 30, 2026.
How has the price of LITHIUM CARBONATE 150 MG CAP changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 150 MG CAP has risen 18.1%. It has been tracked across 434 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 150 MG CAP?
Since Jun 13, 2018, the NADAC for LITHIUM CARBONATE 150 MG CAP has ranged from a low of $0.0626 (Dec 22, 2021) to a high of $0.1032 (Jan 10, 2024), with a median of $0.0813 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 150 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of LITHIUM CARBONATE 150 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LITHIUM CARBONATE 150 MG CAP?
LITHIUM CARBONATE 150 MG CAP (NDC 62332001331) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.